| Aβ | Amyloid-β |
| ACE | Angiotensin-Converting Enzyme |
| AD | Alzheimer’s Disease |
| ALS | Amyotrophic Lateral Sclerosis |
| CNS | Central Nervous System |
| COX2 | Cyclooxygenase-2 |
| EAE | Experimental Autoimmune Encephalomyelitis |
| EDSS | Expanded Disability Status Scale |
| ENOS | Endothelial Nitric Oxide Synthase |
| GBD | Global Burden of Diseases, Injuries, and Risk Factors Study |
| GSH | Reduced Glutathione |
| HD | Huntington’s Disease |
| MAP | Mitogen-Activated Protein |
| MS | Multiple Sclerosis |
| NAD | Nicotinamide Adenine Dinucleotide |
| NADH | Nicotinamide Adenine Dinucleotide Reduced |
| NADP | Nicotinamide Adenine Dinucleotide Phosphate |
| NADPH | Nicotinamide Adenine Dinucleotide Phosphate Reduced |
| NO | Nitric Oxide |
| NRF2 | Nuclear Factor Erythroid 2-Related Factor 2 |
| PD | Parkinson’s Disease |
| RNS | Reactive Nitrogen Species |
| ROS | Reactive Oxygen Species |
| UA | Uric Acid |
| UPDRS | Unified Parkinson’s Disease Rating Scale |
| XDH | Xanthine Dehydrogenase |
| XO | Xanthine Oxidase |
| XOR | Xanthine Oxidoreductase |